Melioidosis: Refining management of a tropical time bomb

The Lancet

Volumn 383, Issue 9919, 2014, Pages 762-764

  Fisher, Dale A ^a   Harris, Patrick N A ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CEFTAZIDIME; COTRIMOXAZOLE; DOXYCYCLINE;

AUSTRALIA; BACTERIAL CLEARANCE; BURKHOLDERIA PSEUDOMALLEI; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; GENOTYPE; HUMAN; IMMUNE RESPONSE; MELIOIDOSIS; NONHUMAN; NOTE; PHAGOCYTE; PRIORITY JOURNAL; REINFECTION; RISK FACTOR; SEROPREVALENCE; THAILAND; TREATMENT DURATION; TREATMENT RESPONSE; VETERAN;

ANTI-BACTERIAL AGENTS; DOXYCYCLINE; FEMALE; HUMANS; MALE; MELIOIDOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84896729358     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62143-1     Document Type: Note

References (13)

1. Time Magazine. Diseases: Viet nam's time bomb. Time Feb 10, 1967. http://content.time.com/time/magazine/article/0,9171,840848,00.html (accessed Oct 23, 2013).
2. Jones AL, Beveridge TJ, Woods DE. Intracellular survival of Burkholderia pseudomallei. Infect Immun 1996; 64: 782-90.
3. Ngauy V, Lemeshev Y, Sadkowski L, Crawford G. Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microbiol 2005; 43: 970-72.
4. Wuthiekanun V, Chierakul W, Langa S, et al. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg 2006; 74: 1074-75.
5. Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med 2012; 367: 1035-44.
6. Currie BJ, Fisher DA, Anstey NM, Jacups SP. Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 2000; 94: 301-04.
7. Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 2010; 4: e900.
8. Limmathurotsakul D, Chaowagul W, Chierakul W, et al. Risk factors for recurrent melioidosis in northeast Thailand. Clin Infect Dis 2006; 43: 979-86.
9. Chetchotisakd P, Chierakul W, Chaowagul W, et al. Trimethoprimsulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, doubleblind, non-inferiority, randomised controlled trial. Lancet 2013; published online Nov 25. http://dx.doi.org/10.1016/S0140-6736(13)61951-0.
10. Maharjan B, Chantratita N, Vesaratchavest M, et al. Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol 2005; 43: 6032-34.
11. Limmathurotsakul D, Wuthiekanun V, Chantratita N, et al. Simultaneous infection with more than one strain of Burkholderia pseudomallei is uncommon in human melioidosis. J Clin Microbiol 2007; 45: 3830-32.
12. Dance DA, Wuthiekanun V, Chaowagul W, White NJ. Interactions in vitro between agents used to treat melioidosis. J Antimicrob Chemother 1989; 24: 311-16.
13. Chaowagul W, Simpson AJ, Suputtamongkol Y, Smith MD, Angus BJ, White NJ. A comparison of chloramphenicol, trimethoprimsulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis 1999; 29: 375-80.